1. What Happens When a Drug Is Given Repeatedly?
When doses are administered repeatedly, a new dose is often given before the previous dose has been completely eliminated. The residual drug from earlier doses therefore contributes to the concentration produced by later doses.
This produces accumulation. With linear pharmacokinetics and a constant dose given at a constant dosing interval, the concentration profile eventually approaches a repeating pattern in which concentrations immediately after and immediately before each dose are the same from one dosing interval to the next.
With repeated dosing, residual drug accumulates until the amount eliminated during each interval balances the amount administered over the interval.
2. Accumulation and Steady State
Accumulation occurs whenever drug from previous doses remains in the body when subsequent doses are administered. The extent of accumulation depends strongly on the relationship between the dosing interval and the drug's elimination rate.
Steady state is reached when, under constant dosing conditions and linear pharmacokinetics, the concentration-time profile repeats from one dosing interval to the next.
For intermittent dosing, it is useful to distinguish three related quantities:
| Quantity | Meaning | Typical interpretation |
|---|---|---|
| Cmax,ss | Steady-state peak concentration | Concentration at the relevant peak time after a dose once steady state has been reached |
| Cmin,ss | Steady-state trough concentration | Concentration immediately before the next dose in a simple repeated-dose regimen |
| Cavg,ss | Average steady-state concentration | Average concentration over a dosing interval |
| Accumulation ratio | Ratio describing how much exposure or concentration has accumulated | Depends on the dosing interval and elimination rate |
The exact relationship among these quantities depends on the route of administration and PK model. The simplest repeated-dose equations arise for an IV bolus regimen in a one-compartment model with first-order elimination.
3. Repeated IV Bolus Dosing in a One-Compartment Model
Consider an IV bolus dose \(D\) administered every \(\tau\) hours. Assume a one-compartment model with first-order elimination, volume of distribution \(V\), and elimination rate constant \(k\).
After a single IV bolus dose, the concentration is:
With repeated dosing, the concentration at any time is the sum of contributions from the current dose and all previous doses that remain in the body.
Immediately after a dose, the current dose adds \(D/V\) to the concentration. At steady state, the residual concentrations from all previous doses form a geometric series.
Using the geometric-series identity gives:
4. The Accumulation Ratio
For a one-compartment model with first-order elimination and repeated IV bolus dosing, the steady-state accumulation ratio is:
Because \(k=\ln(2)/t_{1/2}\), the same relationship can be written in terms of half-life:
This equation makes the role of the dosing interval especially clear. When the dosing interval is short relative to the half-life, substantial residual drug remains before the next dose, so accumulation is greater.
| Dosing interval relative to half-life | Approximate accumulation ratio | Interpretation |
|---|---|---|
| \(\tau=t_{1/2}\) | 2.00 | Peak concentrations at steady state are twice the corresponding single-dose peak |
| \(\tau=2t_{1/2}\) | 1.33 | Moderate accumulation |
| \(\tau=3t_{1/2}\) | 1.14 | Relatively little accumulation |
| \(\tau=4t_{1/2}\) | 1.07 | Small accumulation |
The accumulation ratio is not a universal constant for a drug. It depends on the dosing interval and the elimination behavior represented by the model.
5. Steady-State Peak and Trough Concentrations
For repeated IV bolus dosing in the simple one-compartment model, the steady-state peak concentration immediately after a dose is:
During the dosing interval, the concentration declines exponentially. Immediately before the next dose:
Substituting the peak equation gives:
These equations show why dosing interval matters. A short interval produces less fluctuation between peak and trough because less elimination occurs between doses. A longer interval permits a larger decline before the next dose.
At steady state, the peak and trough repeat each dosing interval even though concentration continues to fluctuate within the interval.
6. Average Steady-State Concentration
For linear pharmacokinetics, the average steady-state concentration over a dosing interval is especially useful because it connects the dosing rate to systemic clearance.
For repeated dosing with bioavailability \(F\):
For an IV regimen, \(F=1\), so:
This relationship reveals an important distinction between dose and dosing rate. If the dose is increased while the dosing interval stays fixed, average concentration increases. If the interval is shortened while the dose remains fixed, the average dosing rate also increases and average concentration rises.
7. How Long Does It Take to Reach Steady State?
A common misconception is that steady state is reached after a fixed number of doses. In fact, the time required is primarily determined by the drug's elimination half-life.
For first-order elimination, the fraction of the eventual steady-state level reached after time \(t\) is:
Equivalently, using the half-life:
| Elapsed time | Approximate fraction of steady state | Remaining gap |
|---|---|---|
| 1 half-life | 50.0% | 50.0% |
| 2 half-lives | 75.0% | 25.0% |
| 3 half-lives | 87.5% | 12.5% |
| 4 half-lives | 93.75% | 6.25% |
| 5 half-lives | 96.875% | 3.125% |
This is the basis of the familiar five-half-life rule: approximately 97% of steady state is reached after five half-lives in a simple first-order system.
8. Why Use a Loading Dose?
If a drug has a long half-life, waiting several half-lives for concentrations to approach the desired range may be impractical. A loading dose can be used to place the amount of drug in the body closer to the amount associated with the desired concentration.
A simplified loading-dose relationship is:
For an IV dose, \(F=1\), giving:
For maintenance dosing under linear conditions, the corresponding relationship is based on clearance:
These equations highlight a useful conceptual distinction:
- Loading dose is primarily related to the volume of distribution and the desired concentration.
- Maintenance dose is primarily related to clearance, dosing interval, and the desired average concentration.
The simple equations are model-dependent and do not automatically account for nonlinear PK, complex distribution, absorption constraints, or clinical safety considerations.
9. Worked Example: Repeated IV Bolus Dosing
Consider a hypothetical drug administered as a 100 mg IV bolus every 8 hours. Assume a one-compartment model with:
- Volume of distribution: \(V=20\) L
- Clearance: \(CL=2.0\) L/h
- Dosing interval: \(\tau=8\) h
Step 1: Calculate the elimination rate constant
Step 2: Calculate the elimination half-life
The dosing interval of 8 hours is therefore slightly longer than one half-life.
Step 3: Calculate the fraction remaining after 8 hours
About 44.9% of the concentration immediately after a dose remains just before the next dose.
Step 4: Calculate the accumulation ratio
Thus, the steady-state peak is about 1.815 times the corresponding peak after the first isolated dose.
Step 5: Calculate the first-dose peak
Step 6: Calculate the steady-state peak
Step 7: Calculate the steady-state trough
Step 8: Calculate the average steady-state concentration
So the repeated-dose regimen produces an average steady-state concentration of 6.25 mg/L, with concentrations fluctuating approximately between 4.08 mg/L and 9.08 mg/L during each steady-state interval.
10. How Concentrations Approach Steady State
The approach to steady state can also be understood dose by dose. For the example above, the fraction of the eventual steady-state peak reached after each dose is determined by the same accumulation process.
| Dose number | Approximate fraction of steady-state peak | Approximate peak concentration |
|---|---|---|
| 1 | 55.1% | 5.00 mg/L |
| 2 | 80.4% | 7.30 mg/L |
| 3 | 91.2% | 8.28 mg/L |
| 4 | 96.0% | 8.72 mg/L |
| 5 | 98.2% | 8.91 mg/L |
| Steady state | 100% | 9.08 mg/L |
The important feature is not the exact number of doses but the underlying time scale. Here, each 8-hour interval represents approximately 1.15 half-lives, so the profile approaches steady state relatively quickly.
After each dose, the new dose adds to the drug already present. As time passes, the increase from each new dose becomes progressively smaller because the system is approaching its repeating steady-state pattern.
11. What Happens When the Dosing Interval Changes?
For a fixed dose, changing the dosing interval changes both accumulation and concentration fluctuation.
| Change | Effect on accumulation | Effect on fluctuation | Effect on average concentration |
|---|---|---|---|
| Shorter \(\tau\) | More accumulation | Smaller peak-to-trough swings | Higher average concentration if dose is unchanged |
| Longer \(\tau\) | Less accumulation | Larger peak-to-trough swings | Lower average concentration if dose is unchanged |
| Smaller dose with same \(\tau\) | Same accumulation ratio | Same relative fluctuation | Lower concentrations |
| Larger dose with same \(\tau\) | Same accumulation ratio | Same relative fluctuation | Higher concentrations |
The accumulation ratio is determined by \(k\) and \(\tau\), not by the absolute dose. Under linear PK, changing the dose scales the concentrations without changing the fractional accumulation pattern.
12. Why Linearity Matters
The simple repeated-dose equations assume linear pharmacokinetics. Under linear conditions, exposure is proportional to dose, and the PK parameters governing the system do not change as dose changes over the relevant range.
This allows a powerful principle: the concentration-time profile after multiple doses can be constructed by adding the profiles produced by individual doses.
This is a form of the principle of superposition. It is one of the key mathematical reasons repeated-dose PK can be described so cleanly in linear models.
If pharmacokinetics become nonlinear, however, the contribution of one dose may depend on the concentrations or doses already present. In that setting, simple superposition and standard accumulation equations may no longer be appropriate.
13. Steady State Does Not Mean Constant Concentration
The phrase steady state can be misleading when first encountered. For an intermittent oral or IV bolus regimen, concentration is not literally constant.
Instead, steady state means that the concentration-time pattern has become periodic. For example:
once steady state has been reached.
There can therefore be substantial within-interval variation at steady state. The peak, trough, and average concentrations remain stable from interval to interval even though concentration continues to change continuously between doses.
14. Steady State With Oral Repeated Dosing
The same accumulation principle applies to repeated oral dosing, but absorption introduces additional features into the concentration-time profile.
For a simple one-compartment model with first-order absorption and elimination, each oral dose generates a concentration-time curve that rises during absorption and falls as elimination dominates. With repeated doses, those curves overlap and accumulate.
The steady-state concentration therefore depends on both the absorption rate constant \(k_a\) and the elimination rate constant \(k\), as well as dose, bioavailability, volume of distribution, and dosing interval.
For oral dosing under linear conditions, the average steady-state concentration remains:
But the exact peak and trough behavior depends on the absorption model and on when the peak occurs. The peak may not occur immediately after the dose as it does for an IV bolus.
15. Common Misconceptions About Steady State
Misconception 1: “Steady state means no fluctuation.”
For intermittent dosing, steady state usually means that the fluctuation pattern repeats from interval to interval. Concentration can still rise and fall substantially.
Misconception 2: “A larger dose reaches steady state faster.”
Under linear PK, increasing the dose increases concentrations but does not change the elimination half-life. Therefore, the fractional approach to steady state occurs on the same time scale.
Misconception 3: “Steady state always occurs after five doses.”
The time to steady state is determined primarily by the half-life. Five half-lives is a useful approximation, but the number of doses required depends on the dosing interval.
Misconception 4: “Accumulation is determined only by the dose.”
The accumulation ratio depends on the relationship between the dosing interval and elimination rate. The same dose can produce very different accumulation patterns with different dosing intervals.
Misconception 5: “Peak and trough concentrations are the same as average concentration.”
They are different summaries. Peak and trough describe specific points in the dosing interval, whereas average concentration summarizes the interval as a whole.
16. Why Steady State Matters in Clinical Pharmacology
Repeated-dose PK is central to designing and interpreting maintenance regimens. The goal is often to maintain exposure within a range that is associated with the desired pharmacologic effect while avoiding excessive concentrations.
Several aspects of the regimen can therefore be considered together:
- Dose: influences the magnitude of each concentration excursion.
- Dosing interval: determines how much elimination occurs between doses.
- Clearance: determines how quickly drug is removed and strongly influences average exposure.
- Volume of distribution: influences concentration magnitude and distribution-related behavior.
- Half-life: determines the time scale for accumulation and washout.
- Bioavailability: determines how much of an extravascular dose reaches systemic circulation.
These relationships are why repeated-dose PK is more than simply “giving the same dose over and over.” The regimen creates a dynamic balance between drug input and drug elimination.
17. A Practical Repeated-Dosing Workflow
- Identify the dosing regimen. Specify dose, route, and dosing interval.
- Identify the relevant PK model. Determine whether a one-compartment, multi-compartment, absorption, or other model is appropriate.
- Determine elimination behavior. Obtain clearance, volume of distribution, or the relevant elimination rate constant and half-life.
- Assess whether linear PK is reasonable. Superposition and simple accumulation equations rely on linearity.
- Calculate accumulation. For the simple IV bolus model, use \(R=1/(1-e^{-k\tau})\).
- Calculate steady-state peak and trough. Use the appropriate model-specific equations.
- Calculate average steady-state concentration. Under linear conditions, use the relationship between dosing rate and clearance.
- Estimate time to steady state. Use the elimination half-life and the desired degree of approach to steady state.
- Interpret the entire profile. Consider peak, trough, average concentration, fluctuation, and clinical context rather than relying on a single summary.
18. Key Takeaways
- Repeated dosing produces accumulation when drug from previous doses remains in the body when subsequent doses are administered.
- At steady state, the concentration-time profile repeats from one dosing interval to the next.
- Steady state does not necessarily mean constant concentration; intermittent dosing produces repeating peak-to-trough fluctuations.
- For repeated IV bolus dosing in a one-compartment model, the accumulation ratio is \(R=1/(1-e^{-k\tau})\).
- Accumulation increases when the dosing interval becomes short relative to the elimination half-life.
- Steady-state peak and trough concentrations depend on dose, volume of distribution, elimination, and dosing interval.
- Under linear pharmacokinetics, average steady-state concentration is determined by the average dosing rate relative to clearance: \(C_{\mathrm{avg,ss}}=FD/(CL\tau)\).
- The time required to approach steady state is governed primarily by the elimination half-life, not by the dose size.
- The familiar five-half-life rule corresponds to approximately 96.9% of steady state in a simple first-order system.
- A loading dose can be used to reach a desired concentration more rapidly when the underlying drug has a long half-life.
- Simple accumulation equations rely on model assumptions, particularly linear pharmacokinetics and an appropriate structural model.
- Repeated-dose PK provides the foundation for understanding maintenance regimens, exposure, accumulation, peak/trough behavior, and therapeutic drug monitoring.
Where to Go Next
A natural progression is to study multiple-dose pharmacokinetics and accumulation in greater detail, including the full concentration-time equations for oral and IV dosing, accumulation factors, peak and trough concentrations, and the relationship between dose, dosing interval, and exposure.
From there, the next useful topics are loading and maintenance doses, oral repeated dosing, absorption and flip-flop kinetics, two-compartment repeated dosing, nonlinear pharmacokinetics, and pharmacokinetic/pharmacodynamic modeling.